Session Details

Global Regulatory Perspectives (GRP) Workshop Session 2 - Risk Assessment for Administration of Non-conforming Products
Wednesday, May 29, 2019 10:15 AM - 11:45 AM
Room 218

David Ritchie, Deputy Director, Head, Bone Marrow Transplant Service, Australia

Steven Oh, PhD, Deputy Director, Office of Tissues and Advanced Therapies, FDA, United States

So-Young Lee, PhD, Scientific Reviewer, Cell and Gene Therapy Products Division, National Institute of Food and Drug Safety Evaluation (NIFDS), Ministry of Food and Drug Safety (MFDS), Korea

Stephan Kadauke, MD, PhD, Assistant Director, Cell and Gene Therapy Lab, CHOP, United States